Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 47 Gastrointestinal 42 Head & Neck 11 Gynecologic 11 Thoracic 10 Other hematologic neoplasm 9 Tumor-Agnostic 8 Genitourinary 6 Lymphoid 5 Endocrine 3 CNS 3 Sarcoma 2 Plasma cell 1 Other solid neoplasm 1 Other neoplasm 1 Other 1 NET 1 Dermatologic 1 Classical hematology 1

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

Exercise 28 Metformin 24 Surveys and Questionnaires 19 Radiotherapy 14 Methods 14 Early Intervention, Educational 13 Counseling 13 Educational Status 12 naloxegol 10 Standard of Care 10 Tirzepatide 9 Nutrition Assessment 9 Diet Therapy 9 Cisplatin 9 Resistance Training 8 Psychiatric Rehabilitation 8 Diet 8 Therapeutics 7 Interviews as Topic 7 alvimopan 6 Liraglutide 6 Fibroblast Growth Factor 7 6 Caloric Restriction 6 semaglutide 5 Radiation 5 Low-Level Light Therapy 5 Injections 5 Exenatide 5 Diet, Mediterranean 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Control Groups × Other × Clear all

NCT01150539 2021-08-25

POLY

Pennington Biomedical Research Center

Phase NA Completed

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡